Proteinuria Triggers Renal Lymphangiogenesis Prior to the Development of Interstitial Fibrosis

PLoS ONE

Volumn 7, Issue 11, 2012, Pages

  Yazdani, Saleh ^a   Poosti, Fariba ^a   Kramer, Andrea B ^a   Mirković, Katarina ^a   Kwakernaak, Arjan J ^a   Hovingh, Menno ^a   Slagman, Maartje C J ^a   Sjollema, Klaas A ^a   de Borst, Martin H ^a   Navis, Gerjan ^a   van Goor, Harry ^a   van den Born, Jacob ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CREATININE; MESSENGER RNA; OSTEOPONTIN; PODOPLANIN; VASCULOTROPIN C; VASCULOTROPIN RECEPTOR 3;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CELL CULTURE; CHRONIC KIDNEY DISEASE; COLLAGEN SYNTHESIS; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FOCAL GLOMERULOSCLEROSIS; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; KIDNEY FIBROSIS; KIDNEY TUBULE; LYMPH VESSEL; LYMPHANGIOGENESIS; MACROPHAGE; MALE; MYOFIBROBLAST; NEPHROSIS; NONHUMAN; PROTEIN EXPRESSION; PROTEINURIA; RAT; SYSTOLIC BLOOD PRESSURE;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; CELL LINE; DISEASE MODELS, ANIMAL; FIBROSIS; GENE EXPRESSION REGULATION; HUMANS; KIDNEY DISEASES; KIDNEY TUBULES; LISINOPRIL; LYMPHANGIOGENESIS; LYMPHATIC VESSELS; MALE; PROTEINURIA; RATS; VASCULAR ENDOTHELIAL GROWTH FACTOR C;

RATTUS;

EID: 84869992864     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0050209     Document Type: Article

References (52)

1. Remuzzi G, Bertani T, (1998) Pathophysiology of progressive nephropathies. N Engl J Med 339(20): 1448-1456.
2. Taal MW, Brenner BM, (2000) Renoprotective benefits of RAS inhibition: From ACEI to angiotensin II antagonists. Kidney Int 57(5): 1803-1817.
3. Bakris GL, (2008) Slowing nephropathy progression: Focus on proteinuria reduction. Clin J Am Soc Nephrol 3 (Suppl 1): S3-10.
4. Eddy AA, (2004) Proteinuria and interstitial injury. Nephrol Dial Transplant 19(2): 277-281.
5. Zoja C, Morigi M, Figliuzzi M, Bruzzi I, Oldroyd S, et al. (1995) Proximal tubular cell synthesis and secretion of endothelin-1 on challenge with albumin and other proteins. Am J Kidney Dis 26(6): 934-941.
6. Reich H, Tritchler D, Herzenberg AM, Kassiri Z, Zhou X, et al. (2005) Albumin activates ERK via EGF receptor in human renal epithelial cells. J Am Soc Nephrol 16(5): 1266-1278.
7. Abbate M, Zoja C, Rottoli D, Corna D, Tomasoni S, et al. (2002) Proximal tubular cells promote fibrogenesis by TGF-beta1-mediated induction of peritubular myofibroblasts. Kidney Int 61(6): 2066-2077.
8. Tang S, Leung JC, Abe K, Chan KW, Chan LY, et al. (2003) Albumin stimulates interleukin-8 expression in proximal tubular epithelial cells in vitro and in vivo. J Clin Invest 111(4): 515-527.
9. Diamond JR, Pesek-Diamond I, (1991) Sublethal X-irradiation during acute puromycin nephrosis prevents late renal injury: Role of macrophages. Am J Physiol 260(6 Pt 2): F779-86.
10. Sean Eardley K, Cockwell P, (2005) Macrophages and progressive tubulointerstitial disease. Kidney Int 68(2): 437-455.
11. Wehrmann M, Bohle A, Held H, Schumm G, Kendziorra H, et al. (1990) Long-term prognosis of focal sclerosing glomerulonephritis. an analysis of 250 cases with particular regard to tubulointerstitial changes. Clin Nephrol 33(3): 115-122.
12. Hirschberg R, Wang S, (2005) Proteinuria and growth factors in the development of tubulointerstitial injury and scarring in kidney disease. Curr Opin Nephrol Hypertens 14(1): 43-52.
13. Kramer AB, Laverman GD, van Goor H, Navis G, (2003) Inter-individual differences in anti-proteinuric response to ACEi in established adriamycin nephrotic rats are predicted by pretreatment renal damage. J Pathol 201(1): 160-167.
14. Aukland K, Bogusky RT, Renkin EM, (1994) Renal cortical interstitium and fluid absorption by peritubular capillaries. Am J Physiol 266(2 Pt 2): F175-84.
15. Zhang T, Guan G, Liu G, Sun J, Chen B, et al. (2008) Disturbance of lymph circulation develops renal fibrosis in rats with or without contralateral nephrectomy. Nephrology (Carlton) 13(2): 128-138.
16. Wang Y, Oliver G, (2010) Current views on the function of the lymphatic vasculature in health and disease. Genes Dev 24(19): 2115-2126.
17. Tammela T, Alitalo K, (2010) Lymphangiogenesis: Molecular mechanisms and future promise. Cell 140(4): 460-476.
18. Meinecke AK, Nagy N, Lago GD, Kirmse S, Klose R, et al. (2012) Aberrant mural cell recruitment to lymphatic vessels and impaired lymphatic drainage in a murine model of pulmonary fibrosis. Blood 119(24): 5931-5942.
19. Kerjaschki D, Regele HM, Moosberger I, Nagy-Bojarski K, Watschinger B, et al. (2004) Lymphatic neoangiogenesis in human kidney transplants is associated with immunologically active lymphocytic infiltrates. J Am Soc Nephrol 15(3): 603-612.
20. Kerjaschki D, Huttary N, Raab I, Regele H, Bojarski-Nagy K, et al. (2006) Lymphatic endothelial progenitor cells contribute to de novo lymphangiogenesis in human renal transplants. Nat Med 12(2): 230-234.
21. Sakamoto I, Ito Y, Mizuno M, Suzuki Y, Sawai A, et al. (2009) Lymphatic vessels develop during tubulointerstitial fibrosis. Kidney Int 75(8): 828-838.
22. Suzuki Y, Ito Y, Mizuno M, Kinashi H, Sawai A, et al. (2012) Transforming growth factor-beta induces vascular endothelial growth factor-C expression leading to lymphangiogenesis in rat unilateral ureteral obstruction. Kidney Int 81(9): 865-879.
23. Kramer AB, Ricardo SD, Kelly DJ, Waanders F, van Goor H, et al. (2005) Modulation of osteopontin in proteinuria-induced renal interstitial fibrosis. J Pathol 207(4): 483-492.
24. Bertani T, Cutillo F, Zoja C, Broggini M, Remuzzi G, (1986) Tubulo-interstitial lesions mediate renal damage in adriamycin glomerulopathy. Kidney Int 30(4): 488-496.
25. Raij L, Azar S, Keane W, (1984) Mesangial immune injury, hypertension, and progressive glomerular damage in dahl rats. 26(2): 137-143.
26. Lokmic Z, Mitchell GM, (2011) Visualisation and stereological assessment of blood and lymphatic vessels. Histol Histopathol 26(6): 781-796.
27. Baluk P, McDonald DM, (2008) Markers for microscopic imaging of lymphangiogenesis and angiogenesis. Ann N Y Acad Sci 1131: 1-12.
28. Abbate M, Zoja C, Remuzzi G, (2006) How does proteinuria cause progressive renal damage? J Am Soc Nephrol 17(11): 2974-2984.
29. Wang Y, Chen J, Chen L, Tay YC, Rangan GK, et al. (1997) Induction of monocyte chemoattractant protein-1 in proximal tubule cells by urinary protein. J Am Soc Nephrol 8(10): 1537-1545.
30. Zoja C, Donadelli R, Colleoni S, Figliuzzi M, Bonazzola S, et al. (1998) Protein overload stimulates RANTES production by proximal tubular cells depending on NF-kappa B activation. Kidney Int 53(6): 1608-1615.
31. Liersch R, Shin J, Bayer M, Schwoeppe C, Schliemann C, et al. (2012) Analysis of a novel highly metastatic melanoma cell line identifies osteopontin as a new lymphangiogenic factor. International Journal of Oncology: in press.
32. Ricardo SD, van Goor H, Eddy AA, (2008) Macrophage diversity in renal injury and repair. J Clin Invest 118(11): 3522-3530.
33. Baluk P, Tammela T, Ator E, Lyubynska N, Achen MG, et al. (2005) Pathogenesis of persistent lymphatic vessel hyperplasia in chronic airway inflammation. J Clin Invest 115(2): 247-257.
34. Ristimaki A, Narko K, Enholm B, Joukov V, Alitalo K, (1998) Proinflammatory cytokines regulate expression of the lymphatic endothelial mitogen vascular endothelial growth factor-C. J Biol Chem 273(14): 8413-8418.
35. Kerjaschki D, (2005) The crucial role of macrophages in lymphangiogenesis. J Clin Invest 115(9): 2316-2319.
36. Kataru RP, Jung K, Jang C, Yang H, Schwendener RA, et al. (2009) Critical role of CD11b+ macrophages and VEGF in inflammatory lymphangiogenesis, antigen clearance, and inflammation resolution. Blood 113(22): 5650-5659.
37. Matsui K, Nagy-Bojarsky K, Laakkonen P, Krieger S, Mechtler K, et al. (2003) Lymphatic microvessels in the rat remnant kidney model of renal fibrosis: Aminopeptidase p and podoplanin are discriminatory markers for endothelial cells of blood and lymphatic vessels. J Am Soc Nephrol 14(8): 1981-1989.
38. Clavin NW, Avraham T, Fernandez J, Daluvoy SV, Soares MA, et al. (2008) TGF-beta1 is a negative regulator of lymphatic regeneration during wound repair. Am J Physiol Heart Circ Physiol 295(5): H2113-27.
39. Oka M, Iwata C, Suzuki HI, Kiyono K, Morishita Y, et al. (2008) Inhibition of endogenous TGF-beta signaling enhances lymphangiogenesis. Blood 111(9): 4571-4579.
40. Avraham T, Clavin NW, Daluvoy SV, Fernandez J, Soares MA, et al. (2009) Fibrosis is a key inhibitor of lymphatic regeneration. Plast Reconstr Surg 124(2): 438-450.
41. Yard BA, Chorianopoulos E, Herr D, van der Woude FJ, (2001) Regulation of endothelin-1 and transforming growth factor-beta1 production in cultured proximal tubular cells by albumin and heparan sulphate glycosaminoglycans. Nephrol Dial Transplant 16(9): 1769-1775.
42. Linares PM, Gisbert JP, (2011) Role of growth factors in the development of lymphangiogenesis driven by inflammatory bowel disease: A review. Inflamm Bowel Dis 17(8): 1814-1821.
43. Guijarro C, Egido J, (2001) Transcription factor-kappa B (NF-kappa B) and renal disease. Kidney Int 59(2): 415-424.
44. Flister MJ, Wilber A, Hall KL, Iwata C, Miyazono K, et al. (2010) Inflammation induces lymphangiogenesis through up-regulation of VEGFR-3 mediated by NF-kappaB and Prox1. Blood 115(2): 418-429.
45. Rodriguez-Iturbe B, Herrera-Acosta J, Johnson RJ, (2002) Interstitial inflammation, sodium retention, and the pathogenesis of nephrotic edema: A unifying hypothesis. Kidney Int 62(4): 1379-1384.
46. Zhang T, Liu G, Sun M, Guan G, Chen B, et al. (2009) Functional, histological and biochemical consequences of renal lymph disorder in mononephrectomized rats. J Nephrol 22(1): 109-116.
47. Cheung L, Han J, Beilhack A, Joshi S, Wilburn P, et al. (2006) An experimental model for the study of lymphedema and its response to therapeutic lymphangiogenesis. BioDrugs 20(6): 363-370.
48. Yin N, Zhang N, Xu J, Shi Q, Ding Y, et al. (2011) Targeting lymphangiogenesis after islet transplantation prolongs islet allograft survival. Transplantation 92(1): 25-30.
49. Hos D, Bock F, Dietrich T, Onderka J, Kruse FE, et al. (2008) Inflammatory corneal (lymph)angiogenesis is blocked by VEGFR-tyrosine kinase inhibitor ZK 261991, resulting in improved graft survival after corneal transplantation. Invest Ophthalmol Vis Sci 49(5): 1836-1842.
50. Nykanen AI, Sandelin H, Krebs R, Keranen MA, Tuuminen R, et al. (2010) Targeting lymphatic vessel activation and CCL21 production by vascular endothelial growth factor receptor-3 inhibition has novel immunomodulatory and antiarteriosclerotic effects in cardiac allografts. Circulation 121(12): 1413-1422.
51. Huggenberger R, Ullmann S, Proulx ST, Pytowski B, Alitalo K, et al. (2010) Stimulation of lymphangiogenesis via VEGFR-3 inhibits chronic skin inflammation. J Exp Med 207(10): 2255-2269.
52. Huggenberger R, Siddiqui SS, Brander D, Ullmann S, Zimmermann K, et al. (2011) An important role of lymphatic vessel activation in limiting acute inflammation. Blood 117(17): 4667-4678.